Douglas J. Manion, President and CEO at Aclaris Therapeutics, Inc. (ACRS), bought 6,300 shares at $7.86 ($50K) on 2023-03-17, disclosed to the SEC on 2023-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.